These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
372 related articles for article (PubMed ID: 30666834)
1. Single Patient Classifier Assay, Microsatellite Instability, and Epstein-Barr Virus Status Predict Clinical Outcomes in Stage II/III Gastric Cancer: Results from CLASSIC Trial. Roh CK; Choi YY; Choi S; Seo WJ; Cho M; Jang E; Son T; Kim HI; Kim H; Hyung WJ; Huh YM; Noh SH; Cheong JH Yonsei Med J; 2019 Feb; 60(2):132-139. PubMed ID: 30666834 [TBL] [Abstract][Full Text] [Related]
2. Microsatellite Instability and Programmed Cell Death-Ligand 1 Expression in Stage II/III Gastric Cancer: Post Hoc Analysis of the CLASSIC Randomized Controlled study. Choi YY; Kim H; Shin SJ; Kim HY; Lee J; Yang HK; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Choi SH; Hong S; Kim JW; Hyung WJ; Noh SH; Cheong JH Ann Surg; 2019 Aug; 270(2):309-316. PubMed ID: 29727332 [TBL] [Abstract][Full Text] [Related]
3. Subtraction of Epstein-Barr virus and microsatellite instability genotypes from the Lauren histotypes: Combined molecular and histologic subtyping with clinicopathological and prognostic significance validated in a cohort of 1,248 cases. Huang SC; Ng KF; Yeh TS; Cheng CT; Lin JS; Liu YJ; Chuang HC; Chen TC Int J Cancer; 2019 Dec; 145(12):3218-3230. PubMed ID: 30771224 [TBL] [Abstract][Full Text] [Related]
4. Clinicopathological and prognostic features of Epstein-Barr virus infection, microsatellite instability, and PD-L1 expression in gastric cancer. Pereira MA; Ramos MFKP; Faraj SF; Dias AR; Yagi OK; Zilberstein B; Cecconello I; Alves VAF; de Mello ES; Ribeiro U J Surg Oncol; 2018 Apr; 117(5):829-839. PubMed ID: 29534305 [TBL] [Abstract][Full Text] [Related]
5. Prognostic implication of molecular subtypes and response to neoadjuvant chemotherapy in 760 gastric carcinomas: role of Epstein-Barr virus infection and high- and low-microsatellite instability. Kohlruss M; Grosser B; Krenauer M; Slotta-Huspenina J; Jesinghaus M; Blank S; Novotny A; Reiche M; Schmidt T; Ismani L; Hapfelmeier A; Mathias D; Meyer P; Gaida MM; Bauer L; Ott K; Weichert W; Keller G J Pathol Clin Res; 2019 Oct; 5(4):227-239. PubMed ID: 31206244 [TBL] [Abstract][Full Text] [Related]
6. Programmed Death-Ligand 1 Expression Is Common in Gastric Cancer Associated With Epstein-Barr Virus or Microsatellite Instability. Ma C; Patel K; Singhi AD; Ren B; Zhu B; Shaikh F; Sun W Am J Surg Pathol; 2016 Nov; 40(11):1496-1506. PubMed ID: 27465786 [TBL] [Abstract][Full Text] [Related]
7. The benefit of microsatellite instability is attenuated by chemotherapy in stage II and stage III gastric cancer: Results from a large cohort with subgroup analyses. Kim SY; Choi YY; An JY; Shin HB; Jo A; Choi H; Seo SH; Bang HJ; Cheong JH; Hyung WJ; Noh SH Int J Cancer; 2015 Aug; 137(4):819-25. PubMed ID: 25614197 [TBL] [Abstract][Full Text] [Related]
8. A Multi-cohort Study of the Prognostic Significance of Microsatellite Instability or Mismatch Repair Status after Recurrence of Resectable Gastric Cancer. An JY; Choi YY; Lee J; Hyung WJ; Kim KM; Noh SH; Choi MG; Cheong JH Cancer Res Treat; 2020 Oct; 52(4):1153-1161. PubMed ID: 32599987 [TBL] [Abstract][Full Text] [Related]
9. Prognostic perspectives of PD-L1 combined with tumor-infiltrating lymphocytes, Epstein-Barr virus, and microsatellite instability in gastric carcinomas. Choi E; Chang MS; Byeon SJ; Jin H; Jung KC; Kim H; Lee KL; Kim W; Park JH; Kim KH; Kim JS; Choi IS; Han DS; Ahn HS; Heo SC Diagn Pathol; 2020 Jun; 15(1):69. PubMed ID: 32498695 [TBL] [Abstract][Full Text] [Related]
10. Adjuvant Chemotherapy in Microsatellite Instability-High Gastric Cancer. Kim JW; Cho SY; Chae J; Kim JW; Kim TY; Lee KW; Oh DY; Bang YJ; Im SA Cancer Res Treat; 2020 Oct; 52(4):1178-1187. PubMed ID: 32599979 [TBL] [Abstract][Full Text] [Related]
11. The Transcriptomic Landscape of Gastric Cancer: Insights into Epstein-Barr Virus Infected and Microsatellite Unstable Tumors. Gullo I; Carvalho J; Martins D; Lemos D; Monteiro AR; Ferreira M; Das K; Tan P; Oliveira C; Carneiro F; Oliveira P Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30018250 [TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic implications of immune classification by PD-L1 expression and CD8-positive tumor-infiltrating lymphocytes in stage II and III gastric cancer patients. Koh J; Ock CY; Kim JW; Nam SK; Kwak Y; Yun S; Ahn SH; Park DJ; Kim HH; Kim WH; Lee HS Oncotarget; 2017 Apr; 8(16):26356-26367. PubMed ID: 28412752 [TBL] [Abstract][Full Text] [Related]
13. Microsatellite instability in sporadic gastric cancer: its prognostic role and guidance for 5-FU based chemotherapy after R0 resection. An JY; Kim H; Cheong JH; Hyung WJ; Kim H; Noh SH Int J Cancer; 2012 Jul; 131(2):505-11. PubMed ID: 21898388 [TBL] [Abstract][Full Text] [Related]
14. Microsatellite instability and Epstein-Barr virus combined with PD-L1 could serve as a potential strategy for predicting the prognosis and efficacy of postoperative chemotherapy in gastric cancer. Yang N; Wu Y; Jin M; Jia Z; Wang Y; Cao D; Qin L; Wang X; Zheng M; Cao X; Jiang J PeerJ; 2021; 9():e11481. PubMed ID: 34046266 [TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus infection serves as an independent predictor of survival in patients with lymphoepithelioma-like gastric carcinoma. Min BH; Tae CH; Ahn SM; Kang SY; Woo SY; Kim S; Kim KM Gastric Cancer; 2016 Jul; 19(3):852-9. PubMed ID: 26265391 [TBL] [Abstract][Full Text] [Related]
16. EBV infection and MSI status significantly influence the clinical outcomes of gastric cancer patients. Shen H; Zhong M; Wang W; Liao P; Yin X; Rotroff D; Knepper TC; Mcleod HL; Zhou C; Xie S; Li W; Xu B; He Y Clin Chim Acta; 2017 Aug; 471():216-221. PubMed ID: 28601671 [TBL] [Abstract][Full Text] [Related]
17. Microsatellite Instability and Effectiveness of Adjuvant Treatment in pT1N1 Gastric Cancer: A Multicohort Study. Oh N; Kim H; Kim KM; Cheong JH; Lee J; Noh SH; Sohn TS; Choi YY; An JY Ann Surg Oncol; 2021 Dec; 28(13):8908-8915. PubMed ID: 34401986 [TBL] [Abstract][Full Text] [Related]
18. Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis. Cheong JH; Yang HK; Kim H; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Kim HY; Lee J; Choi SH; Hong S; Kim JW; Choi YY; Hyung WJ; Jang E; Kim H; Huh YM; Noh SH Lancet Oncol; 2018 May; 19(5):629-638. PubMed ID: 29567071 [TBL] [Abstract][Full Text] [Related]
19. Intratumour T cells, their activation status and survival in gastric carcinomas characterised for microsatellite instability and Epstein-Barr virus infection. Chiaravalli AM; Feltri M; Bertolini V; Bagnoli E; Furlan D; Cerutti R; Novario R; Capella C Virchows Arch; 2006 Mar; 448(3):344-53. PubMed ID: 16261379 [TBL] [Abstract][Full Text] [Related]
20. Predicting the Efficacy of 5-Fluorouracil-Based Adjuvant Chemotherapy in Gastric Cancer by Microsatellite Instability: A Meta-Analysis. Zhao F; Yuan X; Ren D; Shen G; Wang Z; Zheng F; Ahmad R; Ma Z; Zhao J J Environ Pathol Toxicol Oncol; 2019; 38(1):21-28. PubMed ID: 30806287 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]